Navigation Links
Comparable data on maternal and infant in Europe available for the first time
Date:12/11/2008

Finland to 4.9 in Latvia and France. The Netherlands and Scotland also had rates of over 4.0 per 1000.
  • Neonatal mortality: Deaths from 0 to 27 days among babies born alive. These ranged from around 2.0 per 1000 live births in Cyprus, Sweden and Norway to 4.6 in Lithuania and 5.7 in Latvia. Countries with rates over 4.0 per 1000 included Estonia, Hungary, Malta, and Poland.
  • Congenital Anomalies: Although the majority of fetuses affected by a congenital anomaly survive the first year of life, congenital anomaly is a major contributor to fetal and neonatal deaths. Perinatal mortality associated with congenital anomaly varies from 0.2 to 2.6 per 1,000 births, and termination of pregnancy for fetal anomaly varies from 0 to 10.7 per 1,000 births
  • Low birthweight: The percentage of live born babies who weighed less than 2500 g. This varied from 4.2 to 4.3% in Estonia, Finland, and Sweden to 8.5% in Greece, 8.3% in Hungary, and 7.4% in Spain. A geographical pattern characterised the incidence of low birthweight in Europe, with lower rates in the more northerly countries.
  • Preterm birth: The percentage of live births occurring before 37 completed weeks of gestation. This rate ranged from 11.4% in Austria and 8.9% in Germany to 5.3% in Lithuania, 5.5% in Ireland 5.6% in Finland 5.7% in Latvia.
  • Maternal mortality ratios: These vary widely, partly because they are based on very small numbers of deaths and partly reflecting differences in health care, which need fuller investigation.
  • Cerebral palsy: which can be associated with adverse perinatal events, affects an estimated one child out of 500. Even when a common definition is used, cerebral palsy rates in Europe vary from 1.04 to 2.50 children with cerebral palsy per 1,000 children born alive.
  • Obstetric practice varies widely in Europe. This raises questions about what level of obstetric intervention is the most appropriate.

    • Rates
      '/>"/>

    Contact: Sverine Ciancia
    severine.ciancia@inserm.fr
    014-423-6086
    INSERM (Institut national de la sant et de la recherche mdicale)
    Source:Eurekalert

    Page: 1 2 3

    Related medicine news :

    1. Prasco to Distribute Generic Forms of Dorzolamide Hydrochloride-Timolol Maleate and Dorzolamide Hydrochloride Ophthalmic Solutions (Comparable to Mercks COSOPT(R) and TRUSOPT(R) Ophthalmic Solutions)
    2. Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive Patients
    3. Perforomist-comparable pharmacokinetic and pharmacodynamic profile to DPI formulation
    4. Hospital Care in Singapore Now Available to American Patients at Pre-Negotiated, In-Network Rates Far Lower than Comparable Services in the U.S.
    5. NEJM study demonstrates carotid stenting with embolic protection is comparable to surgery
    6. Iomai Study Shows Self-Applied Travelers Diarrhea Vaccine Patch Comparable to Clinician-Applied Vaccine Patch
    7. Abbotts Investigational SIMCOR(R) Offers Comparable LDL Lowering to Simvastatin and Significantly Raises HDL and Lowers Triglycerides in Phase III Study
    8. Real-World Studies of Carotid Artery Stenting Demonstrate Results Comparable to Guidelines for Patients Treated With Surgery
    9. Newborns exposed to maternal smoking more irritable, difficult to soothe
    10. Doc to Dock Completes Maternal Health Wing at Kumasi South Regional Hospital in Ghana
    11. Maternal obesity can program fetal brain to induce adult-onset obesity
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/2/2015)... Los Angeles, CA (PRWEB) , ... September 02, 2015 , ... ... entry featured by the Huffington Post on August 25th, writer Akela Stanfield detailed ... bariatric surgery. While the author acknowledged that she had always seen herself as someone ...
    (Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... swamped with a large stream of mixed documents that include EOBs, payments, and ... documents, while extracting the data needed to reconcile their billing, with one efficient ...
    (Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... Sciences clinical and academic partnership has earned international recognition as a premier center ... disorder that can cause sudden, catastrophic internal bleeding and stroke. , Cure ...
    (Date:9/2/2015)... ... September 02, 2015 , ... Medical ... has completed a recapitalization with new investment partners Beecken Petty O’Keefe & ... each offer extensive expertise and connections within the healthcare industry, which makes ...
    (Date:9/2/2015)... , ... September 02, 2015 , ... Amada Senior Care, ... office in Kansas – its Johnson County location. Amada franchise partners Mike ... has a registered nurse background and spent over 20 years in medical device sales ...
    Breaking Medicine News(10 mins):Health News:Recent Editorial on Bariatric Surgery Acceptance Illuminates a Typical Journey Towards Weight Loss Surgery, Notes Dr. Michael Feiz 2Health News:AliusDoc Launches Enhanced AD-EOB A/R Data Capture Solution to Streamline Processing of Payment-Related Documents Together with EOBs 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 4Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 3Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 4Health News:Amada Senior Care Expands to Greater Kansas City 2
    ... Healthcare,Corporation (Nasdaq: UAHC ), which owns and ... organization in,Tennessee, today announced financial results for its ... increased 82 percent to $8.3 million for the ... revenues of $4.6 million for,the third quarter of ...
    ... MOUNTAIN VIEW, Calif., May 13 IRIDEX,Corporation (Nasdaq: IRIX ... ended March 29, 2008., Revenue for the first quarter ... million reported for the first quarter of 2007. The,Company,s net ... the,first quarter of 2008 compared with a net loss of ...
    ... for, Potential 2008 Launch of MOXATAG; Keflex Product Sales Total $2.4 ... ... GERMANTOWN, Md., May 13 MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: MBRK ... today,announced financial and operational results for the quarter ended March 31,2008., ...
    ... that treat the poor from improving, study finds , , TUESDAY, ... hospitals that treat poor and underserved patients, often called safety-net ... these patients, a new study finds. , These hospitals, which ... sources, do not have the money to improve the quality ...
    ... to treat a rare but well-known genetic disorder may hold ... potentially lethal enlarged hearts, due mainly to high blood pressure, ... common denominator in both phenylketonuria (PKU) and cardiac hypertrophy is ... helps break down the molecule phenylalanine whose buildup is toxic ...
    ... BLOOMFIELD HILLS, Mich., May 13 CJPS Enterprises, ... be holding a,half-day mini-seminar and interactive discussions about ... to increase their,competitiveness, and therefore their worth. This ... June 6th, 2008 and is applicable to both ...
    Cached Medicine News:Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 2Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 3Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 4Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 5Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 6Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 7Health News:IRIDEX Reports First Quarter 2008 Financial Results 2Health News:IRIDEX Reports First Quarter 2008 Financial Results 3Health News:IRIDEX Reports First Quarter 2008 Financial Results 4Health News:IRIDEX Reports First Quarter 2008 Financial Results 5Health News:IRIDEX Reports First Quarter 2008 Financial Results 6Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 2Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 3Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 4Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 5Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 6Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 7Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 8Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 9Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 10Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 11Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 12Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 13Health News:Quality Lags at Safety-Net Hospitals 2Health News:Quality Lags at Safety-Net Hospitals 3Health News:Drug therapy for PKU reverses heart damage 2Health News:Drug therapy for PKU reverses heart damage 3Health News:Drug therapy for PKU reverses heart damage 4Health News:Intellectual Property Buildup Seminar to be Held in Detroit 2
    (Date:9/2/2015)... , Sept. 2, 2015 Advanced Wound ... Summary Advanced dressings have steadily replaced traditional ... a variety of wound indications, such as trauma ... infection control, and physical protection become increasingly critical ... role in standard therapy. This report focuses ...
    (Date:9/2/2015)... , Sept. 2, 2015 About Duchenne ... X-linked disease, which generally affects the male population. ... weakness. The disease is caused due to mutations ... lack of production of dystrophin (a protein essential ... lack of dystrophin weakens muscle function, causes loss ...
    (Date:9/2/2015)...   About ELISA test ELISA test ... is used for measuring the concentration of analytes such ... various types of enzymes such as carbonic anhydrase, glucose ... by photometry or fluorometry. ELISA is used as a ... such as HIV, pernicious anemia, rotavirus, Rocky Mountain spotted ...
    Breaking Medicine Technology:Advanced Wound Dressings - SA Analysis and Market Forecasts 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 3Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 2Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 3
    ... NATICK, Mass., June 20, 2011 Boston Scientific Corporation ... launch of its Mustang™ PTA Balloon Catheter, a highly ... for a wide range of peripheral angioplasty procedures.  The ... U.S., Europe and other international markets. ...
    ... International, Inc. (OTCQX: DATA), a technology and services ... clinical trials industry, today announced the expansion and ... ONE™.  The unified software suite consists of seven ... at the 2011 DIA National Meeting. ...
    Cached Medicine Technology:Boston Scientific Announces Global Launch of Mustang™ PTA Balloon Catheter 2Boston Scientific Announces Global Launch of Mustang™ PTA Balloon Catheter 3DATATRAK Announces Expanded DATATRAK ONE™ Product Suite 2
    ... technology is here! LTF™ (Layered Thin Film) ... test platform that is easy to read, ... as a credit card. What is Infectious ... reason women visit their physician. Vaginal discharge ...
    ... test! QuickScreen multi-panel dip cards offer minimal ... choice of any conceivable combination of 9 ... for your drug testing program. Just dip ... built-in timer tells you when to read ...
    ... SureStep™ Drug Screen Tests are available in ... MDMA (Ecstasy). Designed using Microgenics Antibody Technology, ... only point of care immunoassay targeted to ... both MDA and MDEA but no cross-reactivity ...
    Accu-Stat Home Drug Test for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), Opiates (OPI), and Phencyclidine (PCP)....
    Medicine Products: